GILD acquires IMMU for $88/sh cash—(~$21B)… PR: http://investors.gilead.com/news-releases/news-release-details/gilead-sciences-acquire-immunomedics CC slides: http://investors.gilead.com/static-files/9aa45c9e-e2c8-487c-85c2-1c6558dd0bcd